News

News

March 30, 2021

BioStock article: New data strengthens Follicum’s diabetes project

BioStock published an article on 30 March 2021 about Follicum, which can be read in full below. Follicum, a company that develops tissue repair peptides, has advanced further in its preclinical work with developing a drug candidate for the treatment of diabetes. Through extensive and advanced experimental work, the company believes that the peptides bind […]

February 1, 2021

BioStock article: All patients have completed treatment in Follicum’s phase IIa trial

BioStock published an article on 1 February 2021 about Follicum, which can be read in full below. For Follicum, one of this year’s main events will be the topline result from the ongoing phase IIa study with the company’s candidate FOL-005 for treatment of hair loss. The company announced on Thursday that all patients in […]

December 17, 2020

BioStock article: Follicum takes a step closer to phase III entering 2021

BioStock published an article on 17 December 2020 about Follicum, which can be read in full below. A productive 2020 for Follicum is capped off by the completion of patient recruitment for its phase II hair growth study for determining the best dose and treatment duration of candidate FOL-005. BioStock spoke with Follicum’s CEO Jan […]

November 25, 2020

Analysis of Follicum now published

On 25 November 2020, Aktiespararna published their analysis of Follicum on their website. The analysis can also be read on Follicum’s webpage. Read the analysis at Aktiespararna.se For further information, please contact: Jan Alenfall – CEO, Follicum AB Telephone: +46 (0)709 31 51 15 Email: info@follicum.com About Follicum AB Follicum AB (Spotlight: FOLLI) develops drugs […]

October 9, 2020

BioStock article: Follicum finalises patient recruitment in hair growth study

BioStock published an article on 9 October 2020 about Follicum, which can be read in full below. Alopecia patients have very few treatment options available to them. Those that exist are often ineffective and come with a multitude of side effects, and they mainly target men. Follicum’s FOL-005 is a compound in clinical development that […]

August 19, 2020

BioStock article: Follicum reaches milestone in hair study

BioStock published an article on 19 August 2020 about Follicum, which can be read in full below. Yesterday, Follicum announced that they have recruited over 50 per cent of the intended patient group for their ongoing phase IIa trial with the topical formulation of the hair growth stimulating candidate FOL-005. Thus, the study is well on […]

June 25, 2020

BioStock article: New patent notice rounds off an eventful six months for Follicum

BioStock published an article on 25 June 2020 about Follicum, which can be read in full below. During the first half of 2020, Follicum has started, paused and resumed a phase II study with its primary candidate FOL-005. An international patent application has been filed regarding its newly developed topical formulation as a carrier of […]